Literature DB >> 24834438

New Prognostic Markers: The Pathway from Research to Clinical Practice.

Caroline Savage, Andrew J Vickers.   

Abstract

Entities:  

Year:  2009        PMID： 24834438      PMCID： PMC4019230     

Source DB:  PubMed          Journal:  Grand rounds Urol


× No keyword cloud information.
  46 in total

Review 1.  Phases of biomarker development for early detection of cancer.

Authors:  M S Pepe; R Etzioni; Z Feng; J D Potter; M L Thompson; M Thornquist; M Winget; Y Yasui
Journal:  J Natl Cancer Inst       Date:  2001-07-18       Impact factor: 13.506

2.  Prostate-specific membrane antigen levels in sera from healthy men and patients with benign prostate hyperplasia or prostate cancer.

Authors:  M L Beckett; L H Cazares; A Vlahou; P F Schellhammer; G L Wright
Journal:  Clin Cancer Res       Date:  1999-12       Impact factor: 12.531

3.  Dear Dr. [Bence] Jones...

Authors:  S N Kahn
Journal:  Clin Chem       Date:  1991-09       Impact factor: 8.327

Review 4.  Statistical issues in the evaluation of screening and early detection modalities.

Authors:  Ruth Etzioni
Journal:  Urol Oncol       Date:  2007-11-07       Impact factor: 3.498

Review 5.  Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis.

Authors:  Andrew W Roddam; Michael J Duffy; Freddie C Hamdy; Anthony Milford Ward; Julietta Patnick; Christopher P Price; Janet Rimmer; Cathie Sturgeon; Peter White; Naomi E Allen
Journal:  Eur Urol       Date:  2005-09       Impact factor: 20.096

6.  Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.

Authors:  Arun Sreekumar; Laila M Poisson; Thekkelnaycke M Rajendiran; Amjad P Khan; Qi Cao; Jindan Yu; Bharathi Laxman; Rohit Mehra; Robert J Lonigro; Yong Li; Mukesh K Nyati; Aarif Ahsan; Shanker Kalyana-Sundaram; Bo Han; Xuhong Cao; Jaeman Byun; Gilbert S Omenn; Debashis Ghosh; Subramaniam Pennathur; Danny C Alexander; Alvin Berger; Jeffrey R Shuster; John T Wei; Sooryanarayana Varambally; Christopher Beecher; Arul M Chinnaiyan
Journal:  Nature       Date:  2009-02-12       Impact factor: 49.962

7.  Analysis of Mel-18 expression in prostate cancer tissues and correlation with clinicopathologic features.

Authors:  Wei Wang; Tianxin Lin; Jian Huang; Weilie Hu; Kewei Xu; Jun Liu
Journal:  Urol Oncol       Date:  2009-04-22       Impact factor: 3.498

Review 8.  The use of PCA3 in the diagnosis of prostate cancer.

Authors:  Daphne Hessels; Jack A Schalken
Journal:  Nat Rev Urol       Date:  2009-05       Impact factor: 14.432

9.  Statistical methods to correct for verification bias in diagnostic studies are inadequate when there are few false negatives: a simulation study.

Authors:  Angel M Cronin; Andrew J Vickers
Journal:  BMC Med Res Methodol       Date:  2008-11-11       Impact factor: 4.615

10.  A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden.

Authors:  Andrew J Vickers; Angel M Cronin; Gunnar Aus; Carl-Gustav Pihl; Charlotte Becker; Kim Pettersson; Peter T Scardino; Jonas Hugosson; Hans Lilja
Journal:  BMC Med       Date:  2008-07-08       Impact factor: 8.775
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.